September 2025

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online
India making major strides towards self-reliance in high end medical devices
1 September 2025

India making major strides towards self-reliance in high end medical devices

Shri Amit Agrawal, Secretary, Department of Pharmaceuticals, highlighted Indias transformation into an emerging hub for medical technology at the 17th CII Global MedTech Summit, themed Innovating for a Healthier Future – Advancing MedTech for Global Impact: Make in India, Make for the World, in New Delhi.
1 September 2025
SEC recommends approval for Bayer’s Darolutamide tablets for Prostate Cancer treatment in India
The Subject Expert Committee Oncology, in its 25th meeting held at CDSCO headquarters, has recommended granting permission to Bayer Pharmaceuticals Pvt. Ltd. for the manufacture and marketing of Darolutamide Film-Coated Tablets 300 mg in India.
1 September 2025
Astrazeneca's Baxdrostat reduces BP in patients with uncontrolled hypertension in clinical trials
Positive full results from the ​BaxHTN Phase III trial showed AstraZeneca ​baxdrostat, demonstrated a statistically significant and clinically meaningful reduction in mean seated systolic blood pressure (SBP) at two doses 2mg and 1mg compared with placebo at 12 weeks. Results were seen in patients with hard-to-control uncontrolled and resistant hypertension who received baxdrostat or placebo on top of standard of care.